Alyeska Investment Group’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-38,383
| Closed | -$2.08M | – | 736 |
|
|
2021
Q2 | $2.08M | Hold |
38,383
| – | – | 0.02% | 505 |
|
|
2021
Q1 | $2.29M | Sell |
38,383
-20,000
| -34% | -$1.19M | 0.03% | 440 |
|
|
2020
Q4 | $3.05M | Sell |
58,383
-467
| -0.8% | -$24.4K | 0.04% | 330 |
|
|
2020
Q3 | $2.85M | Hold |
58,850
| – | – | 0.04% | 310 |
|
|
2020
Q2 | $3.05M | Buy |
58,850
+34,338
| +140% | +$1.78M | 0.05% | 312 |
|
|
2020
Q1 | $1.07M | Buy |
+24,512
| New | +$1.07M | 0.02% | 274 |
|
|
2019
Q4 | – | Sell |
-4,895
| Closed | -$161K | – | 424 |
|
|
2019
Q3 | $161K | Hold |
4,895
| – | – | ﹤0.01% | 348 |
|
|
2019
Q2 | $377K | Buy |
+4,895
| New | +$377K | ﹤0.01% | 372 |
|
|
2018
Q3 | – | Sell |
-7,500
| Closed | -$1.3M | – | 424 |
|
|
2018
Q2 | $1.3M | Buy |
+7,500
| New | +$1.3M | 0.01% | 354 |
|